/ /

Lisette Hilton
Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.
FDA approves etanercept biosimilar for psoriasis, psoriatic arthritis
The FDA approved the biosimilars Erelzi for plaque psoriasis and Enbrel for psoriatic arthritis.
Study highlights what helps, doesn’t help ADHD kids with homework
New research examines the effects of behavioral, psychostimulant, and combined treatments on homework issues among children with attention-deficit/hyperactivity disorder (ADHD).
Genomic profile products enhanced to better predict immunotherapy response
Foundation Medicine, based in Cambridge, Mass., announced in late August the addition of new clinical markers to its genomic profile products FoundationOne and FoundationOne Heme.
Common pediatric disorders in skin of color
Pediatric atopic dermatitis and acne have some similarities when these present in skin of color and lighter-skin children. But there are important differences when these common skin conditions affect darker skin types. An expert discusses how treatments should be approached.
Can costs be contained?
There’s a lot of blame to go around when it comes to why drug costs are rising in dermatology. We’ll let the research do the finger pointing.
MMF relatively safe for off-label use in children, adults with severe AD
For patients with severe AD, treatment with the systemic immunomodulator methotrexate mycophenolate mofetil is a viable option, according to a recent review of the drug.
Laser fundamentals
A review of basic laser knowledge will help dermatologists improve operating room and patient safety as well as ensure optimal outcomes. One expert offers tips for assessing space, equipment and patients.
Top 3 trends for tattoo removal
The options for tattoo removal are more numerous and more effective than ever. Picosecond technology, quad treatments, Perfluorodecalin, macrophage targeting, and Q-switched lasers allow people with ink regret more effective ways to return their skin to pre-tat status.
Pediatric labeling for OxyContin: Pros & Cons
In the throes of an opioid epidemic, the US Food and Drug Administration (FDA) decided in August 2015 to expand the indications for OxyContin, an extended-release form of the narcotic oxycodone, to children aged 11 years and older. The decision sparked outrage in those who fear the move might fuel increasing opioid addiction among young Americans.
When to consider a Zika diagnosis
As Zika spreads and proliferates in the U.S., dermatologists need to familiarize themselves with population risk factors and techniques to diagnose and treat this disease

Poll

View Results